EPS for General Dynamics (GD) Expected At $2.38; Exelixis Has 1.23 Sentiment

January 14, 2018 - By Clifton Ray

Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. The company has market cap of $8.99 billion. The companyÂ’s products include CABOMETYX for the treatment of patients with advanced renal cell carcinoma, who have received prior anti-angiogenic therapy; and COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid carcinoma. It has a 62 P/E ratio. The Company’s CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors, which has shown clinical anti-tumor activity in approximately 20 forms of cancer and is the subject of a broad clinical development program.

Analysts expect General Dynamics Corporation (NYSE:GD) to report $2.38 EPS on January, 26.They anticipate $0.24 EPS change or 9.16% from last quarter’s $2.62 EPS. GD’s profit would be $710.63 million giving it 22.12 P/E if the $2.38 EPS is correct. After having $2.52 EPS previously, General Dynamics Corporation’s analysts see -5.56% EPS growth. The stock increased 2.47% or $5.08 during the last trading session, reaching $210.59. About 1.89M shares traded or 63.14% up from the average. General Dynamics Corporation (NYSE:GD) has risen 36.41% since January 14, 2017 and is uptrending. It has outperformed by 19.71% the S&P500.

Among 20 analysts covering General Dynamics Corporation (NYSE:GD), 12 have Buy rating, 2 Sell and 6 Hold. Therefore 60% are positive. General Dynamics Corporation had 62 analyst reports since July 31, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Barclays Capital on Monday, May 2. As per Wednesday, May 10, the company rating was downgraded by Bernstein. The firm has “Buy” rating by RBC Capital Markets given on Friday, August 11. As per Friday, July 7, the company rating was maintained by Jefferies. Drexel Hamilton upgraded the shares of GD in report on Monday, December 21 to “Buy” rating. The rating was maintained by Jefferies on Tuesday, September 12 with “Buy”. The firm earned “Buy” rating on Friday, August 11 by Jefferies. The firm earned “Hold” rating on Friday, July 31 by Drexel Hamilton. The firm earned “Buy” rating on Wednesday, October 25 by Jefferies. On Tuesday, August 2 the stock rating was maintained by Argus Research with “Buy”.

Investors sentiment increased to 1.08 in Q3 2017. Its up 0.17, from 0.91 in 2017Q2. It improved, as 52 investors sold General Dynamics Corporation shares while 313 reduced holdings. 89 funds opened positions while 304 raised stakes. 255.81 million shares or 0.28% less from 256.53 million shares in 2017Q2 were reported. Envestnet Asset Mgmt stated it has 0.03% in General Dynamics Corporation (NYSE:GD). 1,499 are held by Burke & Herbert Savings Bank & Company. Perkins Coie has 560 shares. Amalgamated Bank reported 0.2% of its portfolio in General Dynamics Corporation (NYSE:GD). Provise Management Llc reported 0.39% stake. Wisconsin-based Mason Street Advsrs Llc has invested 0.19% in General Dynamics Corporation (NYSE:GD). Laurel Grove Capital Limited Liability Company holds 1.03% of its portfolio in General Dynamics Corporation (NYSE:GD) for 9,650 shares. Honeywell Int invested in 123,300 shares or 0.89% of the stock. Asset Mngmt One Limited reported 412,654 shares. Berkshire Asset Management Ltd Com Pa holds 5,729 shares or 0.13% of its portfolio. Vanguard Gru, a Pennsylvania-based fund reported 20.23 million shares. Locust Wood Cap Advisers Limited Com reported 125,039 shares. Profund Advsrs Limited holds 0.06% or 7,475 shares. Edge Wealth holds 2.56% or 41,213 shares in its portfolio. White Pine Lc holds 2,693 shares or 0% of its portfolio.

General Dynamics Corporation operates as an aerospace and defense firm worldwide. The company has market cap of $62.88 billion. It operates through four business groups: Aerospace; Combat Systems; Information Systems and Technology; and Marine Systems. It has a 19.95 P/E ratio. The Aerospace group designs, develops, makes, and outfits business-jet aircraft; provides aircraft services, such as maintenance, repair, aircraft management, charter, fixed-base operational, and staffing services; and performs aircraft completion services for other original equipment manufacturers.

The stock increased 1.00% or $0.3 during the last trading session, reaching $30.38. About 2.03M shares traded. Exelixis, Inc. (EXEL) has risen 266.48% since January 14, 2017 and is uptrending. It has outperformed by 249.78% the S&P500.

Ratings analysis reveals 100% of Exelixis’s analysts are positive. Out of 2 Wall Street analysts rating Exelixis, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. EXEL was included in 2 notes of analysts from September 15, 2016. The firm has “Overweight” rating by Piper Jaffray given on Monday, October 10. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, September 15.

Since January 1, 0001, it had 0 insider buys, and 9 sales for $24.37 million activity.

Analysts await Exelixis, Inc. (NASDAQ:EXEL) to report earnings on February, 26. They expect $0.12 EPS, 0.00% or $0.00 from last year’s $0.12 per share. EXEL’s profit will be $35.50M for 63.29 P/E if the $0.12 EPS becomes a reality. After $0.26 actual EPS reported by Exelixis, Inc. for the previous quarter, Wall Street now forecasts -53.85% negative EPS growth.

Meditor Group Ltd holds 64.06% of its portfolio in Exelixis, Inc. for 17.42 million shares. Rhenman & Partners Asset Management Ab owns 1.05 million shares or 3.25% of their US portfolio. Moreover, Bogle Investment Management L P De has 1.3% invested in the company for 790,148 shares. The United Kingdom-based Old Mutual Global Investors (Uk) Ltd. has invested 1.06% in the stock. Insight Capital Research & Management Inc, a California-based fund reported 50,818 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News